Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Start Tentatively Higher; UK GDP To Come

Mon, 30th Sep 2019 08:47

(Alliance News) - Stock prices in London opened marginally higher on Monday, showing stability after a sell-off in the US on Friday, while investors look ahead to a UK GDP reading at 0930 BST.

The FTSE 100 was up 3.20 points at 7,429.85. The FTSE 250 was up 21.14 points, or 0.1%, at 19,992.09. The AIM All-Share was down 0.1%, at 872.20.

The Cboe UK 100 index was up 0.1% at 12,607.02. The Cboe UK 250 was flat at 17,841.62. The Cboe UK Small Companies was flat at 10,901.18.

In European equities, the CAC 40 index in Paris was down 0.1% and the DAX 30 in Frankfurt down 0.2%.

"Markets are focused on US-China relations at the start of the week following a report Friday that the US would consider banning Chinese listings on US markets as part of the trade war," said Markets.com analyst Neil Wilson.

In New York on Friday, the Dow Jones Industrial Average closed down 0.3%, S&P 500 down 0.5% and Nasdaq Composite down 1.1%.

"So we have another salvo on the US-China front. Yet more noise to contend with. This fits into the playbook of Trump negotiations - float something to ramp pressure and get a reaction. Always put the opposition on the back foot. Refuted or not, the implication of this is two-fold: first that the trade/tech war is spiralling ever wider in its scope; secondly it does not bode especially well for the high level talks due to restart October 10," Wilson added.

In the FTSE 100, GlaxoSmithKline was the best performer, up 2.0% after the drugmaker said its GSK3359609 cancer treatment delivered "promising anti-tumour activity" in head and neck squamous cell carcinoma.

DS Smith was up 0.7% after the UK Competition & Markets Authority said it has accepted undertakings offered by the packaging firm and Liqui-Box related to an acquisition. As a result, the CMA won't refer the planned sale of a DS Smith business to Liqui-Box for Phase 2 review.

In August, the UK monopoly regulator had said it was considering proposals made by Liqui-Box related to its agreed acquisition of the flexible plastics packaging arm of DS Smith, after the watchdog had raised competition concerns relating to the deal.

At the other end of the FTSE 100, Whitbread was the worst performer, down 1.3% after Barclays downgraded the Premier Inn hotel chain owner to Equal Weight from Overweight.

In the FTSE 250, HomeServe was up 2.7% after RBC Capital raised the home emergency services company to Outperform from Sector Perform.

Elsewhere, Woodford Patient Capital Trust was down 1.8% after reporting a sharp decline in net asset value over the first half.

At June 30, Woodford Patient Capital said net asset value per share stood at 72.00 pence, compared to 97.61p at December 31, a 26% drop.

Woodford Patient's net assets slipped 19% over the first six months of 2019, ending the half at GBP654.2 million, compared to GBP807.2 million six months prior.

The Japanese Nikkei 225 index closed down 0.6%. In China, the Shanghai Composite closed down 0.9%, while the Hang Seng index in Hong Kong is up 0.6%.

Financial markets in China will be closed over the coming week as the country celebrates National Day. The seven-day holiday which starts on Tuesday and ends on October 7, is called Golden Week.

Chinese manufacturers saw a modest improvement in conditions in September, with production and total new orders expanding. The seasonally adjusted purchasing managers' index rose to 51.5 in September from 50.4 in August. Despite the "modest" improvement, it still marks the highest reading since February 2018, according to Caixin data, released on Monday.

Any reading above 50 represents expansion as opposed to contraction in the sector.

The September growth was driven by a faster rise in overall new work compared to August, with new orders rising at its quickest level since March 2018. New orders were being driven by "firmer" domestic demand.

The pound was quoted at USD1.2307 early Monday, flat against USD1.2310 at the London equities close on Friday, as the UK Conservative Party conference continues in Manchester.

UK Prime Minister Boris Johnson will close the conference when he delivers his keynote speech on Wednesday.

"Speaking yesterday, Johnson reiterated that the deal agreed by Theresa May would not be brought back to parliament, yet he still felt that there was a 'good chance' of getting a revised deal from the EU. Compared to those political developments, UK economic data have continued to be of secondary importance to markets and that is likely to be the case again this week," commented analysts at Lloyds.

The economic calendar on Monday has Germany unemployment figures at 0855 BST and inflation data at 1300 BST.

UK GDP is at 0930 BST. The final reading of second-quarter GDP growth is expected to hold steady on an annual basis at 1.2%.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.